These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 35368070)

  • 1. Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients.
    Johannsson G; Touraine P; Feldt-Rasmussen U; Pico A; Vila G; Mattsson AF; Carlsson M; Korbonits M; van Beek AP; Wajnrajch MP; Gomez R; Yuen KCJ
    J Clin Endocrinol Metab; 2022 Jun; 107(7):1906-1919. PubMed ID: 35368070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database.
    Spielhagen C; Schwahn C; Möller K; Friedrich N; Kohlmann T; Moock J; Kołtowska-Häggström M; Nauck M; Buchfelder M; Wallaschofski H
    Growth Horm IGF Res; 2011 Feb; 21(1):1-10. PubMed ID: 21093334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency.
    Hoybye C; Jönsson P; Monson JP; Koltowska-Häggström M; Hána V; Geffner M; Abs R
    Eur J Endocrinol; 2007 Nov; 157(5):589-96. PubMed ID: 17984238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis.
    Tritos NA; Johannsson G; Korbonits M; Miller KK; Feldt-Rasmussen U; Yuen KC; King D; Mattsson AF; Jonsson PJ; Koltowska-Haggstrom M; Klibanski A; Biller BM
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2018-29. PubMed ID: 24694339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Neoplasm During GH Replacement in Adults With Pituitary Deficiency Following Malignancy: A KIMS Analysis.
    Krzyzanowska-Mittermayer K; Mattsson AF; Maiter D; Feldt-Rasmussen U; Camacho-Hübner C; Luger A; Abs R
    J Clin Endocrinol Metab; 2018 Feb; 103(2):523-531. PubMed ID: 29228199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety.
    Abs R; Bengtsson BA; Hernberg-Stâhl E; Monson JP; Tauber JP; Wilton P; Wüster C
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):703-13. PubMed ID: 10468941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction.
    Yuen KC; Koltowska-Häggström M; Cook DM; Fox JL; Jönsson PJ; Geffner ME; Abs R
    Eur J Endocrinol; 2013 Oct; 169(4):511-9. PubMed ID: 23904277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
    Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
    Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).
    Popovic V; Mattsson AF; Gaillard RC; Wilton P; Koltowska-Häggström M; Ranke MB
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4449-54. PubMed ID: 20610598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone (GH) deficiency and GH replacement therapy in patients previously treated for Cushing's disease.
    Boguszewski CL
    Pituitary; 2022 Oct; 25(5):760-763. PubMed ID: 35552989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in baseline characteristics over 20 years of adults with growth hormone (GH) deficiency on GH replacement therapy.
    Höybye C; Burman P; Feldt-Rasmussen U; Hey-Hadavi J; Aydin F; Camacho-Hubner C; Mattsson AF
    Eur J Endocrinol; 2019 Dec; 181(6):629-638. PubMed ID: 31590143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to growth hormone therapy guidelines in a real-world French cohort of adult patients with growth hormone deficiency.
    Borson-Chazot F; Chabre O; Salenave S; Klein M; Brac de la Perriere A; Reznik Y; Kerlan V; Hacques E; Villette B
    Ann Endocrinol (Paris); 2021 Feb; 82(1):59-68. PubMed ID: 33290752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database.
    Kelestimur F; Jonsson P; Molvalilar S; Gomez JM; Auernhammer CJ; Colak R; Koltowska-Häggström M; Goth MI
    Eur J Endocrinol; 2005 Apr; 152(4):581-7. PubMed ID: 15817914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone replacement does not increase mortality in patients with childhood-onset growth hormone deficiency.
    Berglund A; Gravholt CH; Olsen MS; Christiansen JS; Stochholm K
    Clin Endocrinol (Oxf); 2015 Nov; 83(5):677-83. PubMed ID: 26147754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone deficient patients after traumatic brain injury--baseline characteristics and benefits after growth hormone replacement--an analysis of the German KIMS database.
    Kreitschmann-Andermahr I; Poll EM; Reineke A; Gilsbach JM; Brabant G; Buchfelder M; Fassbender W; Faust M; Kann PH; Wallaschofski H
    Growth Horm IGF Res; 2008 Dec; 18(6):472-8. PubMed ID: 18829359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Traumatic brain injury as a relevant cause of growth hormone deficiency in adults: A KIMS-based study.
    Casanueva FF; Leal A; Koltowska-Häggström M; Jonsson P; Góth MI
    Arch Phys Med Rehabil; 2005 Mar; 86(3):463-8. PubMed ID: 15759229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary function and the response to GH therapy in patients with Langerhans cell histiocytosis: analysis of the KIMS database.
    Touraine P; Sagna Y; Mattsson AF; Burman P; Van Beek AP; Carlsson MO; Aydin F; Feldt-Rasmussen U; Camacho-Hübner C
    Eur J Endocrinol; 2022 Sep; 187(3):373-381. PubMed ID: 35830276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone therapy in adults with growth hormone deficiency: a critical assessment of the literature.
    He X; Barkan AL
    Pituitary; 2020 Jun; 23(3):294-306. PubMed ID: 32060708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.